Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2024-03-15 | 2024-04-19 | 222464 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2020-06-24 | 2020-08-17 | 118778 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187235 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-02-09 | 2023-02-23 | 184109 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-07 | 2021-06-14 | 138978 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-08-27 | 2021-09-14 | 144669 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-11-12 | 2021-11-29 | 149170 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-01-21 | 2022-02-28 | 153288 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-08 | 155324 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-03-25 | 2022-04-29 | 157332 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2017-10-23 | 2017-11-29 | 26646 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2017-11-21 | 2018-01-08 | 29949 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2018-01-17 | 2018-05-15 | 36347 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2018-02-01 | 2018-05-15 | 37983 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2017-07-11 | 2017-12-07 | 15409 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2017-08-24 | 2017-10-11 | 20245 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2019-03-05 | 2019-04-26 | 77896 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |